¼¼°èÀÇ Áª½ÃŸºó ¿°»ê¿° ½ÃÀå(2024-2028³â)
Global Gemcitabine Hydrochloride Market 2024-2028
»óǰÄÚµå : 1544416
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 132 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,502,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,603,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Áª½ÃŸºó ¿°»ê¿° ½ÃÀåÀº 2023-2028³â 3¾ï 2,380¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 7.08%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â Áª½ÃŸºó ¿°»ê¿° ½ÃÀå¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¿¡ ´ëÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¾Ï Àα¸ Áõ°¡, ½ÅÈï±¹ÀÇ È­Çпä¹ý ¾à¹°¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ½Å¾à ½ÂÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2024³â
Á¾·á ¿¬µµ 2028³â
¿¹Ãø ±â°£ 2024-2028³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â ´ëºñ[2024³â] 6.49%
CAGR 7.08%
ÁõºÐ ±Ý¾× 3¾ï 2,380¸¸ ´Þ·¯

ÀÌ º¸°í¼­´Â ÇâÈÄ ¸î ³â µ¿¾È Áª½ÃŸºó ¿°»ê¿° ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ÆÄÀÌÇÁ¶óÀÎÀ» °­È­ÇÏ´Â °­·ÂÇÑ R&D Ȱµ¿À» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î Ä¡·á ¿É¼Ç°ú »õ·Î¿î ¿ëµµÀÇ Á¶ÇÕ°ú ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °¡´É¼ºÀÌ ³ôÀº ¹«±â ¼ºÀå Àü·«ÀÇ Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå »óȲ

Á¦3Àå ½ÃÀå ±Ô¸ð Æò°¡

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦5Àå Five Forces ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

Á¦7Àå °í°´ »óȲ

Á¦8Àå Áö¿ªº° »óȲ

Á¦9Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ

Á¦10Àå °æÀï »óȲ

Á¦11Àå °æÀï ºÐ¼®

Á¦12Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The gemcitabine hydrochloride market is forecasted to grow by USD 323.8 mn during 2023-2028, accelerating at a CAGR of 7.08% during the forecast period. The report on the gemcitabine hydrochloride market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing cancer population drive market growth, growing preference for chemotherapy drugs in developing countries, and approval of new drugs fuels market growth.

Technavio's gemcitabine hydrochloride market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.49%
CAGR7.08%
Incremental Value$323.8 mn

By Type

By Geographical Landscape

This study identifies the robust r and d activities fueling pipeline as one of the prime reasons driving the gemcitabine hydrochloride market growth during the next few years. Also, novel treatment options coupled with new applications and increasing inorganic growth strategies likely to fuel market growth will lead to sizable demand in the market.

The report on the gemcitabine hydrochloride market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gemcitabine hydrochloride market vendors that include Apotex Inc., Biocon Ltd., Cipla Inc., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, Ingenus Pharmaceuticals LLC, Intas Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Lianyungang Jinkang Pharmaceutical Technology Co. Ltd., Merck KGaA, Nichi Iko Pharmaceutical Co. Ltd., Pfizer Inc., Shilpa Medicare Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd.. Also, the gemcitabine hydrochloride market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â